 Jon S. Morrow, M.D., Ph.D.
Raymond Yesner Professor of Pathology and Chair; Professor of Molecular, Cellular, and Developmental Biology; Chief of Pathology at YNHH.
Department of Pathology
Yale University School of Medicine P.O. Box 208023 310 Cedar St., BML 140 New Haven, CT 06520-8023
Office: (203) 785-3624
Lab: (203) 785-2771
Fax: (203) 785-7037
email: jon.morrow@yale.edu
-
Training:
- B.S.(chemistry) Indiana University, Bloomington, IN, 1969
Ph.D.(Biochemistry/Biophysics) Indiana University, Bloomington, IN, 1974 M.D., Cum Laude, Yale University School of Medicine, New Haven, CT, 1976
-
Expertise:
- Molecular architecture of the cortical cytoskeleton, and post-translational regulation of its assembly and stability by protein phosphorylation and second-messenger pathways; structural basis of cytoskeletal function, the role of the spectrin based cytoskeleton in signal transduction and the control of cell diffentiation, vesicle trafficking, and topographic membrane assembly; contributions of the cortical cytoskeleton to the phenotypic alterations of malignant cells, “leaky channel dominant” disorders, including the process of mechanosensatin and the role fo cytoskeleton in the control of cell volume, ion-channel conductance, and the contributions of these processs to familial hypertension and hemolytic disease.
-
Research Interests:
- Central to the integrated function of multicellular organisms is cell contact mediated signaling and the spatial organizations of specialized membrane-surface domains. While many factors contribute, recent evidence indicates that the spectrin based membrane skeleton plays a pivotal role in these processes. Current research in the laboratory is aimed at understanding three aspects of the spectrin membrane skeleton in erythrocytes, epithelial cells, and neurons: 1) The factors that mediate its polarized assembly with specific surface membrane receptor domains; 2) the nature of the proteins that interact with spectrin and their role in signal transduction, cell differentiation, vesicle trafficking, and topographic membrane assembly; and 3) the molecular basis of diseases that involve spectrin or any of its associated proteins, including contributions of the cortical cytoskeleton to the phenotypic alterations of malignant cells and the molecular pathology of acquired and inherited disorders involving this structure. Our studies on the erythrocyte focus on a molecular understanding of how specific proteins that cause human disease.
Hemolytic Disease, Degenerative Brain Disease, spectrin, Autopsy Pathology, Renal Pathology, Medical Informatics, Computer Aided Instruction (CAI), Telepathology
-
Professional Service:
- Editor-in-Chief, Laboratory Investigation Journal
Member, Yale Cancer Center Member, Committee on Cooperative Research Member, Medical School GA Subcommittee
Other Links:
Morrow Lab
Laboratory Investigation
Community of Science (COS) Database
Selected Publications:Brown, T. L., Patil, S., Cianci, C. D., Morrow, J. S. and Howe, P. H. 1999. TGFbeta induces caspase 3 independent cleavage of alpha II spectrin (alpha-fodrin) coincident with apoptosis. J. Biol. Chem. in Pathology
Innes, D. S., Sinard, J. H., Gilligan, D. M., Snyder, L. M., Gallagher, P. G. and Morrow, J. S. 1998. Exclusion of the stomatin, a-adducin and b-adducin loci in a large kindred with dehydrated hereditary stomatocytosis. Am. J. Hematology 60:72-4.
Sinard, J. H., Stewart, G. W., Argent, A. C., Stabach, P. R., Gilligan, D. M. and Morrow, J. S. 1998. Utilization of an 86 bp exon generates a novel adducin isoform (b4) lacking the MARCKS homology domain. Biochim Biophys Acta 1396:57-66.
Wang, K. K. W., Posmantur, R., Nath, R., McGinnis, K., Whitton, M., Talanian, R. V., Glantz, S. B. and Morrow, J. S. 1998. Simultaneous degradation of aII and bII spectrin by caspase 3 (CPP32) in apoptotic cells. J. Biol. Chem 273:22490-22497.
Zhang, Z., Devarajan, P., Dorfman, A. L. and Morrow, J. S. 1998. Structure of the Ankyrin Binding Domain of a-Na,K-ATPase. J. Biol. Chem 273:18681-18684.
Stankewich, M. C., Tse, W. T., Peters, L. L., Ch’ng, Y., John, K. M., Stabach, P. R., Devarajan, P., Morrow, J. S. and Lux, S. E. 1998. A widely expressed betaIII spectrin associated with Golgi and cytoplasmic vesicles. Proc. Natl. Acad. Sci (USA) 95:14158-14163.
Search PubMed Database for Jon Morrow
This page was last modified on: 09/19/2008
|